281 related articles for article (PubMed ID: 26776603)
1. A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.
Honne K; Hallgrímsdóttir I; Wu C; Sebro R; Jewell NP; Sakurai T; Iwamoto M; Minota S; Jawaheer D
Arthritis Res Ther; 2016 Jan; 18():12. PubMed ID: 26776603
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
Cui J; Stahl EA; Saevarsdottir S; Miceli C; Diogo D; Trynka G; Raj T; Mirkov MU; Canhao H; Ikari K; Terao C; Okada Y; Wedrén S; Askling J; Yamanaka H; Momohara S; Taniguchi A; Ohmura K; Matsuda F; Mimori T; Gupta N; Kuchroo M; Morgan AW; Isaacs JD; Wilson AG; Hyrich KL; Herenius M; Doorenspleet ME; Tak PP; Crusius JB; van der Horst-Bruinsma IE; Wolbink GJ; van Riel PL; van de Laar M; Guchelaar HJ; Shadick NA; Allaart CF; Huizinga TW; Toes RE; Kimberly RP; Bridges SL; Criswell LA; Moreland LW; Fonseca JE; de Vries N; Stranger BE; De Jager PL; Raychaudhuri S; Weinblatt ME; Gregersen PK; Mariette X; Barton A; Padyukov L; Coenen MJ; Karlson EW; Plenge RM
PLoS Genet; 2013 Mar; 9(3):e1003394. PubMed ID: 23555300
[TBL] [Abstract][Full Text] [Related]
3. Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study.
Suarez-Gestal M; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
Arthritis Res Ther; 2010; 12(2):R72. PubMed ID: 20423481
[TBL] [Abstract][Full Text] [Related]
4. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
[TBL] [Abstract][Full Text] [Related]
5. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Manrique-Arija S; Ordoñez MDC; Alegre-Sancho JJ; Narvaez J; Navarro-Sarabia F; Moreira V; Valor L; Garcia-Portales R; Marquez A; Gomez-Reino JJ; Martin J; Gonzalez A
PLoS One; 2019; 14(2):e0213073. PubMed ID: 30818333
[TBL] [Abstract][Full Text] [Related]
7. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.
Mathews RJ; Robinson JI; Battellino M; Wong C; Taylor JC; ; Eyre S; Churchman SM; Wilson AG; Isaacs JD; Hyrich K; Barton A; Plant D; Savic S; Cook GP; Sarzi-Puttini P; Emery P; Barrett JH; Morgan AW; McDermott MF
Ann Rheum Dis; 2014 Jun; 73(6):1202-10. PubMed ID: 23687262
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.
Julià A; Fernandez-Nebro A; Blanco F; Ortiz A; Cañete JD; Maymó J; Alperi-López M; Fernández-Gutierrez B; Olivè A; Corominas H; Erra A; Acosta-Colman I; Alonso A; López-Lasanta M; Tortosa R; Tornero J; Marsal S
Pharmacogenomics J; 2016 Apr; 16(2):147-50. PubMed ID: 25896534
[TBL] [Abstract][Full Text] [Related]
9. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
[TBL] [Abstract][Full Text] [Related]
10. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.
Umiċeviċ Mirkov M; Cui J; Vermeulen SH; Stahl EA; Toonen EJ; Makkinje RR; Lee AT; Huizinga TW; Allaart R; Barton A; Mariette X; Miceli CR; Criswell LA; Tak PP; de Vries N; Saevarsdottir S; Padyukov L; Bridges SL; van Schaardenburg DJ; Jansen TL; Dutmer EA; van de Laar MA; Barrera P; Radstake TR; van Riel PL; Scheffer H; Franke B; Brunner HG; Plenge RM; Gregersen PK; Guchelaar HJ; Coenen MJ
Ann Rheum Dis; 2013 Aug; 72(8):1375-81. PubMed ID: 23233654
[TBL] [Abstract][Full Text] [Related]
12. A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis.
Nishimoto T; Seta N; Anan R; Yamamoto T; Kaneko Y; Takeuchi T; Kuwana M
Clin Exp Rheumatol; 2014; 32(2):211-7. PubMed ID: 24321457
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients.
Coulthard LR; Taylor JC; Eyre S; ; Robinson JI; Wilson AG; Isaacs JD; Hyrich K; Emery P; Barton A; Barrett JH; Morgan AW; McDermott MF
Ann Rheum Dis; 2011 Jan; 70(1):98-103. PubMed ID: 20805296
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
Cui J; Saevarsdottir S; Thomson B; Padyukov L; van der Helm-van Mil AH; Nititham J; Hughes LB; de Vries N; Raychaudhuri S; Alfredsson L; Askling J; Wedrén S; Ding B; Guiducci C; Wolbink GJ; Crusius JB; van der Horst-Bruinsma IE; Herenius M; Weinblatt ME; Shadick NA; Worthington J; Batliwalla F; Kern M; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Seldin MF; Moreland LW; Behrens TW; Allaart CF; Criswell LA; Huizinga TW; Tak PP; Bridges SL; Toes RE; Barton A; Klareskog L; Gregersen PK; Karlson EW; Plenge RM
Arthritis Rheum; 2010 Jul; 62(7):1849-61. PubMed ID: 20309874
[TBL] [Abstract][Full Text] [Related]
15. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
Front Immunol; 2019; 10():1459. PubMed ID: 31312201
[No Abstract] [Full Text] [Related]
16. Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
Umićević Mirkov M; Janss L; Vermeulen SH; van de Laar MA; van Riel PL; Guchelaar HJ; Brunner HG; Albers CA; Coenen MJ
Ann Rheum Dis; 2015 Dec; 74(12):2183-7. PubMed ID: 25114059
[TBL] [Abstract][Full Text] [Related]
17. GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.
Acosta-Colman I; Palau N; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Ballina J; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Canela-Xandri O; Alonso A; López Lasanta M; Tortosa R; Julià A; Marsal S
Pharmacogenomics; 2013 May; 14(7):727-34. PubMed ID: 23651021
[TBL] [Abstract][Full Text] [Related]
18. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.
Márquez A; Ferreiro-Iglesias A; Dávila-Fajardo CL; Montes A; Pascual-Salcedo D; Perez-Pampin E; Moreno-Ramos MJ; García-Portales R; Navarro F; Moreira V; Magro C; Caliz R; Ferrer MA; Alegre-Sancho JJ; Joven B; Carreira P; Balsa A; Vasilopoulos Y; Sarafidou T; Cabeza-Barrera J; Narvaez J; Raya E; Cañete JD; Fernández-Nebro A; Ordóñez Mdel C; de la Serna AR; Magallares B; Gomez-Reino JJ; González A; Martín J
Arthritis Res Ther; 2014 Mar; 16(2):R66. PubMed ID: 24612463
[TBL] [Abstract][Full Text] [Related]
19. Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.
Hassan B; Maxwell JR; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG
Rheumatology (Oxford); 2010 Jan; 49(1):43-7. PubMed ID: 19926672
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek population.
Zervou MI; Myrthianou E; Flouri I; Plant D; Chlouverakis G; Castro-Giner F; Rapsomaniki P; Barton A; Boumpas DT; Sidiropoulos P; Goulielmos GN
PLoS One; 2013; 8(9):e74375. PubMed ID: 24040234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
